PulseAugur
EN
LIVE 16:46:35
ENTITY Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer

Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer

PulseAugur coverage of Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer — every cluster mentioning Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. TOOL · CL_196840 ·

    New antibodies target previously inaccessible KRAS cancer mutations

    Researchers have developed a novel antibody-based therapy that targets a common weakness in cancer cells, specifically mutations in the KRAS protein. This new approach leverages the cell's natural surface display system…